The need for routine eye examinations

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 8, 2004, Pages 2539-2542

  Taylor, Hugh R ^a   Vu, Hien T V ^a   McCarty, Catherine A ^a,b   Keeffe, Jill E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; EYE DISEASE; FAMILY HISTORY; FEMALE; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; STANDARD; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VICTORIA; VISION DISORDERS; VISION SCREENING; VISUAL ACUITY; VISUAL FIELDS;

EID: 3242883872     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-1198     Document Type: Article

References (28)

1. VanNewkirk M, Weih LM, McCarty CA, Taylor HR. The cause-specific prevalence of bilateral visual impairment in Victoria, Australia: The Visual Impairment Project. Ophthalmology. 2001;108:960-967.
2. Foran S, Mitchell P, Wang JJ. Five-year change in visual acuity and incidence of visual impairment: The Blue Mountains Eye Study. Ophthalmology. 2003;110:41-50.
3. Klaver CC, Wolfs RCW, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653-658.
4. Klein R, Klein BE, Lee KE, Cruickshanks KJ, Chappell RJ. Changes in visual acuity in a population over a 10-year period: The Beaver Dam Eye Study. Ophthalmology. 2001;108:1757-1766.
5. Orr P, Barron Y, Schein OD, Rubin GS, West SK. Eye care utilization by older Americans: The SEE Project-Salisbury Eye Evaluation. Ophthalmology. 1999;106:904-909.
6. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in East Baltimore. N Engl J Med. 1991;325:1440-1442.
7. Dandona R, Dandona L, Srinivas M, et al. Moderate visual impairment in India: the Andhra Pradesh Eye Disease Study. Br J Ophthalmol. 2002;86:373-377.
8. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001;108:697-704.
9. McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR. Risk factors for age-related maculopathy: The Visual Impairment Project. Arch Ophthalmol. 2001;119:1455-1462.
10. McCarty CA, Mukesh BN, Fu CL, Taylor HR. The epidemiology of cataract in Australia. Am J Ophthalmol. 1999;128:446- 465.
11. West S. Does smoke get in your eyes? JAMA. 1992;268:1025-1026.
12. Wensor MD, McCarty CA, Stanislavsky YL, Livingston PM, Taylor HR. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology. 1998;105:733-739.
13. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Family history and risk of primary open angle glaucoma: The Baltimore Eye Survey. Arch Ophthalmol. 1994;112:69 -73.
14. Liou HL, McCarty CA, Jin CL, Taylor HR. Prevalence and predictors of under-corrected refractive errors in the Victorian population. Am J Ophthalmol. 1999;127:590-596.
15. Dandona R, Dandona L, Srinivas M, Giridhar P, McCarty CA, Rao G. Population-based assessment of refractive error in India: the Andhra Pradesh eye disease study. Clin Exp Ophthalmol. 2002;30:84-93.
16. McCarty CA, Nanjan MB, Taylor HR. Vision impairment predicts five-year mortality. Br J Ophthalmol. 2001;85:322-326.
17. Klein BEK, Klein R, Lee KE, Cruickshanks KJ. Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time: The Beaver Dam Eye Study. Ophthalmology. 1998;105:160-164.
18. Wang JJ, Mitchell P, Cumming RG, Smith W. Visual impairment and nursing home placement in older Australians: The Blue Mountains Eye Study. Ophthalmol Epidemiol. 2003;10:3-13.
19. Rovener BW, Ganguli M. Depression and disability associated with impaired vision: the MoVies Project. J Am Geriatr Soc. 1998;46:617-619.
20. Taylor HR. Eye care for the future: The Weisenfeld Lecture., Invest Ophthalmol Vis Sci. 2003;44:1413-1418.
21. Weih LM, Hassell JB, Keeffe J. Assessment of the impact of vision impairment. Invest Ophthalmol Vis Sci. 2002;43:927-935.
22. Preferred Practice Pattern Diabetic Retinopathy. San Francisco: American Academy of Ophthalmology; 1998.
23. NHMRC Working Party on Diabetic Retinopathy. Management of Diabetic Retinopathy: Clinical Practice Guidelines. Canberra, Australia: Australian Government Publishing Service; 1997.
24. Krans HMJ, Porta M, Keen H. Diabetes Care and Research in Europe: the St. Vincent Declaration Action Programme. Copenhagen: World Health Organization, Regional Office for Europe; 1992.
25. The Eye M. D. Association. Policy Statement: Frequency of Ocular Examinations. San Francisco: American Academy of Ophthalmology, 2001. (available at http://www.medem.com/search/article_ display.cfm
26. Primary Care Committee. Recommendations for Regular Optometric Care. Washington, DC: American Optometric Association; 2003. (available at http://www.aoa.org/clincare/primary-care.asp)
27. Frequency of Eye Examination Policy. Surry Hills, New South Wales, Australia: The Royal Australian and New Zealand College of Ophthalmologists; 2003.
28. Livingston PM, Carson CA, Stanislavsky YL, Lee SE, Guest CS, Taylor HR. Methods for a population based study: The Melbourne Visual Impairment Project. Ophthalmol Epidemiol. 1994;1:139-148.